Related Experiment Video

Updated: Jun 13, 2026

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions

Smaragda Oikonomidi1, Konstantinos Kostikas, Ioannis Kalomenidis

  • 1Respiratory Medicine Department, University of Thessaly Medical School, Larissa, Greece.

Respiration; International Review of Thoracic Diseases
|May 11, 2010
PubMed
Abstract

Insights

Matrix metalloproteinases (MMPs) like MMP-8 and MMP-9 can help distinguish complicated parapneumonic effusions from uncomplicated ones. The MMP-2/MMP-9 ratio in pleural fluid is a strong indicator for this differentiation.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Diagnostic Biomarkers

Background:

  • Matrix metalloproteinases (MMPs) are implicated in fibrosis and remodeling during parapneumonic pleural effusion progression to empyema.
  • Understanding MMP roles is crucial for managing pleural effusion complications.

Purpose of the Study:

  • To assess matrix metalloproteinase-2 (MMP-2), MMP-8, and MMP-9 levels in parapneumonic pleural effusions.
  • To evaluate the utility of these MMPs in differentiating uncomplicated from complicated parapneumonic effusions.

Main Methods:

  • Analyzed pleural fluid and serum from 208 patients with various effusions.
  • Included 60 parapneumonic effusions (uncomplicated, complicated, empyema).
  • Quantified MMP-2, MMP-8, and MMP-9 concentrations using immunoassay.

Main Results:

  • Pleural fluid MMP-8 and MMP-9 were elevated in complicated effusions and empyema compared to uncomplicated ones.
  • MMP-2 levels were higher in uncomplicated effusions.
  • The pleural fluid MMP-2/MMP-9 ratio showed high sensitivity (94.1%) and specificity (77.8%) for differentiating complicated from uncomplicated effusions.

Conclusions:

  • Pleural fluid MMP-2, MMP-8, and MMP-9 levels offer valuable insights for distinguishing between uncomplicated and complicated parapneumonic effusions.
  • The MMP-2/MMP-9 ratio is a promising biomarker for clinical application in managing parapneumonic effusions.

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...